BLOG / 🇺🇸 United States · · daily

Insider Trading Pulse — July 10, 2026

Insider Trading Pulse

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

Today's insider trading digest reveals a pronounced bearish tilt among senior insiders, with multiple C-suite officers executing significant sales, often under Rule 10b5-1 plans. The most material insider sales occurred at Aktis Oncology (CMO and COO sold ~$1.7M combined), Casey's General Stores (CFO sold $4.78M), and Insmed (Chair & CEO sold $583K).

Notable director-level selling was seen at Hormel Foods ($495K) and United Therapeutics ($179K). The day was dominated by negative sentiment transactions, though several routine option exercises and tax-withholding filings were neutral. A positive signal emerged from Angel Oak Financial Strategies Income Term Trust, where a 10% owner purchased $40M in senior notes. The data suggests insider conviction is weakest in biotech and consumer staples, while capital allocation trends show continued share-based compensation and director awards across technology and healthcare sectors.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4

Tracking the trend? Catch up on the prior Insider Trading Pulse digest from July 09, 2026.

Investment Signals (10)

  • Casey's General Stores (BEARISH)
    ▲

    CFO Bramlage Stephen P Jr sold $4.78M at $838.16, representing 16% of his post-trade holdings. The sale is large relative to position and not under a 10b5-1 plan, signaling potential valuation concern at current levels

  • Aktis Oncology ↓ (BEARISH)
    ▲

    Both CMO Czibere Akos and COO Ron-Bigger Shulamit sold substantial shares (~$1.7M combined) after exercising cheap options ($3.66-$4.95 strike vs $27.95 sale price). The pattern of top medical and operating officers both cashing out simultaneously is a strong negative signal on near-term outlook

  • Angel Oak Financial Strategies Income Trust (BULLISH)
    ▲

    10% owner MetLife Investment Management bought $40M in Series C Senior Notes at par, a significant vote of confidence in the trust's credit quality and yield. This institutional purchase at scale suggests attractive risk-adjusted returns

  • Insmed ↓ (BEARISH)
    ▲

    Chair & CEO Lewis William sold $583K at $116.55 after exercising options at $17-$30, a multi-bagger gain. While under a 10b5-1 plan, the magnitude of the sale (5,005 shares) from the CEO is notable and suggests profit-taking at elevated levels

  • Tempus AI ↓ (BEARISH)
    ▲

    CEO Fukushima Ryan sold $794K at $56.80 under a 10b5-1 plan, with multiple tranches totaling ~$1.78M. The CEO's consistent selling pattern, even under a plan, signals potential overvaluation in the AI healthcare space

  • JFrog ↓ (BEARISH)
    ▲

    CEO Shlomi Ben Haim sold $735K at $94.72 under a 10b5-1 plan, with total sales of ~$1.42M. Despite holding 4.58M shares, the CEO's regular selling pattern warrants monitoring for further insider activity

  • Sea Ltd ↓ (BEARISH)
    ▲

    COO Ye Gang sold $1.07M at $107.83 under a 10b5-1 plan, while CCO Wang Yanjun sold $58.9K. The COO's larger sale is notable given the company's recent turnaround, suggesting management may be locking in gains

  • Hormel Foods ↓ (BEARISH)
    ▲

    Director Bhojwani Gary C. sold $495K at $24.51, a significant sale for a director. Given Hormel's consumer staples exposure and current valuation, this sale may indicate concerns about margin pressure or demand trends

  • Domino's Pizza
    ▲

    EVP & Chief Tech Officer GARCIA KELLY E sold $145K at $297.01 after exercising options at $136.89, a routine but notable insider sale. The tech officer's sale comes as the company invests heavily in digital infrastructure [NEUTRAL/BEARISH]

  • United Therapeutics ↓ (BEARISH)
    ▲

    Director MALCOLM JAN sold $179K at $550.59 after exercising RSUs, a small but notable sale at elevated stock prices. The director's decision to sell immediately upon vesting suggests caution at current levels

Risk Flags (9)

  • Aktis Oncology - Dual Insider Exodus↓
    ▼

    Both CMO and COO sold nearly all exercisable shares within days, with CMO holding only 4,371 shares post-sale. This near-complete liquidation by two top medical and operating officers is a severe red flag for clinical-stage biotech investors

  • Casey's General Stores - CFO Large Sale
    ▼

    CFO sold $4.78M in a single transaction, representing ~16% of his remaining holdings. The absence of a 10b5-1 plan for this sale raises governance concerns and suggests possible negative non-public information

  • Hormel Foods - Director Selling at 52-Week Lows↓
    ▼

    Director sold $495K at $24.51, near the stock's 52-week low. Insider selling at depressed prices is particularly concerning as it signals lack of confidence in a turnaround

  • Insmed - CEO Profit-Taking at Highs↓
    ▼

    CEO sold $583K after exercising deeply in-the-money options. While under a 10b5-1 plan, the timing near all-time highs suggests management sees limited near-term upside

  • Tempus AI - CEO Consistent Selling↓
    ▼

    CEO Fukushima sold ~$1.78M across multiple transactions this period. The pattern of persistent insider selling in a recently public company is a red flag for retail investors

  • Sea Ltd - COO Large Sale Post-Turnaround↓
    ▼

    COO sold $1.07M at $107.83, representing a significant position reduction. The sale comes after the company's return to profitability, suggesting management may doubt sustainability

  • Domino's Pizza - Tech Officer Sale
    ▼

    EVP of Tech sold $145K at $297.01, a modest but notable sale from a key executive overseeing digital transformation. Could signal internal concerns about tech investments

  • Semtech - COO Multiple Sales↓
    ▼

    COO Silberstein Asaf sold $436K across 6 transactions at $124-$130, a pattern of consistent selling that may indicate operational headwinds in the semiconductor space

  • Immunovant - COO Small Sale↓
    ▼

    COO Gloria Melanie sold $76.3K at $39.53, a small but notable sale from a key operating executive in a clinical-stage biotech. The sale amount is modest but the signal is negative

Opportunities (8)

  • Angel Oak Financial Strategies Income Trust - Institutional Vote of Confidence
    ◆

    MetLife Investment Management's $40M purchase of Series C Senior Notes at par provides a strong endorsement of the trust's credit quality. Investors should consider the trust's current yield and potential for capital appreciation as MetLife's large position creates a floor

  • Planet Labs PBC - Director Accumulation↓
    ◆

    Multiple directors (Raymond, Reese, Gadde, Bass, Brennan) were awarded 6,479 Class A shares each, signaling board-level confidence in the company's space-based data platform. The consistent director awards suggest alignment with long-term value creation

  • Seres Therapeutics - Option Awards to Multiple Directors↓
    ◆

    Five directors/officers were awarded stock options (6,500-50,000 each), indicating the board is incentivizing leadership at current levels. The options provide upside potential if the microbiome therapeutics pipeline advances

  • Maris Tech Ltd. - Broad-Based Share Awards↓
    ◆

    CFO and two other officers were awarded 88,451-125,951 ordinary shares each, a significant equity grant that aligns management with shareholders. The awards suggest confidence in the company's defense technology growth trajectory

  • Ally Financial - Director Share Awards↓
    ◆

    Two directors were awarded 1,034 and 300 common shares respectively at $45.95, a modest but positive signal from the board. The awards come as the company navigates the auto finance cycle

  • Lowe's Companies - Phantom Stock Awards
    ◆

    Two directors were awarded phantom stock at $213.00, suggesting the board sees value at current prices. The phantom stock structure aligns director compensation with shareholder returns

  • Valvoline - CEO Deferred Stock Units↓
    ◆

    CEO Flees Lori Ann was awarded 25 deferred stock units at $37.98, a small but symbolic award that ties CEO compensation to long-term stock performance. The deferred structure indicates management's commitment to sustained value creation

  • C.H. Robinson Worldwide - CFO Tax Withholding↓
    ◆

    CFO Lee Damon J. had 4,698 shares withheld for taxes at $190.95, a routine transaction but notable given the logistics company's current valuation. The CFO retains 36,736 shares post-transaction, indicating continued alignment

Sector Themes (5)

  • Biotech Insider Selling Surge
    ◆

    Three biotech companies (Aktis Oncology, Insmed, Immunovant) saw senior officers sell shares, with Aktis being the most severe. The pattern suggests clinical-stage biotech insiders are taking profits amid uncertain FDA pipelines and high cash burn rates

  • Consumer Staples Insider Caution
    ◆

    Casey's General Stores (CFO -$4.78M) and Hormel Foods (Director -$495K) saw significant insider selling, indicating management concerns about consumer spending trends and margin compression in the current inflationary environment

  • Tech Insider Profit-Taking at Highs
    ◆

    Sea Ltd (COO -$1.07M), JFrog (CEO -$735K), and Tempus AI (CEO -$794K) all saw senior insiders sell under 10b5-1 plans. The pattern suggests tech insiders view current valuations as attractive for locking in gains

  • Director Compensation Through Equity Awards
    ◆

    Multiple companies (Planet Labs, Seres Therapeutics, Maris Tech, Ally Financial, Lowe's) awarded stock or options to directors, a common practice that aligns board interests with shareholders but dilutes existing holders

  • 10b5-1 Plan Usage Dominates
    ◆

    The majority of insider sales (Sea Ltd, Domino's, Semtech, Insmed, United Therapeutics, Tempus AI, JFrog) were executed under Rule 10b5-1 plans, reducing the signaling power of individual transactions but still providing aggregate trend data

Watch List (8)

  • Aktis Oncology↓
    👁

    Watch for additional insider filings after CMO and COO sold nearly all shares. Any further insider sales or lack of insider buying would confirm negative outlook. Next catalyst: clinical trial data updates

  • Casey's General Stores
    👁

    Monitor CFO Bramlage's future transactions after the $4.78M sale. The absence of a 10b5-1 plan makes any subsequent sales more significant. Next earnings call expected in September 2026

  • Insmed↓
    👁

    Watch CEO Lewis William's trading pattern after $583K sale. The company's rare disease pipeline (Treprostinil) has upcoming FDA decisions that could drive volatility

  • Tempus AI↓
    👁

    Monitor CEO Fukushima's continued selling under 10b5-1 plan. As a recent IPO, insider selling patterns are critical for valuation. Next earnings call expected August 2026

  • Sea Ltd↓
    👁

    Watch COO Ye Gang's remaining holdings after $1.07M sale. The company's e-commerce and gaming segments face competitive pressures in Southeast Asia

  • Hormel Foods↓
    👁

    Monitor director Bhojwani's future transactions after $495K sale at 52-week lows. The consumer staples sector faces margin pressure from input costs

  • Seres Therapeutics↓
    👁

    Track option exercises by directors after awards. The microbiome company's pipeline progress and potential partnership announcements are key catalysts

  • Angel Oak Financial Strategies Income Trust
    👁

    Monitor MetLife's future purchases after $40M note investment. The trust's yield and credit quality will be in focus

Filing Analyses (50)
Aktis Oncology, Inc. 4 negative materiality 7/10

10-07-2026

Chief Medical Officer Czibere Akos sold 30,829 Common Stock at $27.95 (~$862K). 5 transactions reported in total. Czibere Akos holds 4,371 shares after the transaction.

  • · Chief Medical Officer Czibere Akos exercised/converted 50,000 Common Stock at $4.95 (~$248K)
  • · Chief Medical Officer Czibere Akos sold 14,800 Common Stock at $27.13 (~$401K)
  • · Chief Medical Officer Czibere Akos sold 30,829 Common Stock at $27.95 (~$862K)
  • · Chief Medical Officer Czibere Akos sold 4,371 Common Stock at $28.71 (~$125K)
  • · Chief Medical Officer Czibere Akos exercised/converted 50,000 Stock Option (Right to Buy)
Aktis Oncology, Inc. 4 negative materiality 8/10

10-07-2026

Chief Operating Officer Ron-Bigger Shulamit sold 30,000 Common Stock at $27.94 (~$838K). 5 transactions reported in total. Ron-Bigger Shulamit holds 4,200 shares after the transaction.

  • · Chief Operating Officer Ron-Bigger Shulamit exercised/converted 50,000 Common Stock at $3.66 (~$183K)
  • · Chief Operating Officer Ron-Bigger Shulamit sold 15,800 Common Stock at $27.13 (~$429K)
  • · Chief Operating Officer Ron-Bigger Shulamit sold 30,000 Common Stock at $27.94 (~$838K)
  • · Chief Operating Officer Ron-Bigger Shulamit sold 4,200 Common Stock at $28.75 (~$121K)
  • · Chief Operating Officer Ron-Bigger Shulamit exercised/converted 50,000 Stock Option (Right to Buy)
Sea Ltd 4 negative materiality 2/10

10-07-2026

CCO and GC Wang Yanjun sold 547 Class A ordinary shares at $107.71 (~$58.9K). 10 transactions reported in total. Wang Yanjun holds 40,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CCO and GC Wang Yanjun sold 390 Class A ordinary shares at $102.09 (~$39.8K)
  • · CCO and GC Wang Yanjun sold 331 Class A ordinary shares at $102.99 (~$34.1K)
  • · CCO and GC Wang Yanjun sold 60 Class A ordinary shares at $104.35 (~$6.26K)
  • · CCO and GC Wang Yanjun sold 418 Class A ordinary shares at $105.13 (~$43.9K)
  • · CCO and GC Wang Yanjun sold 1 Class A ordinary shares at $105.80 (~$106)
  • · CCO and GC Wang Yanjun sold 93 Class A ordinary shares at $105.53 (~$9.81K)
  • · CCO and GC Wang Yanjun sold 73 Class A ordinary shares at $106.51 (~$7.78K)
  • · CCO and GC Wang Yanjun sold 547 Class A ordinary shares at $107.71 (~$58.9K)
Sea Ltd 4 negative materiality 6/10

10-07-2026

COO Ye Gang sold 9,900 Class A ordinary shares at $107.83 (~$1.07M). 10 transactions reported in total. Ye Gang holds 440,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · COO Ye Gang sold 8,000 Class A ordinary shares at $101.84 (~$815K)
  • · COO Ye Gang sold 6,600 Class A ordinary shares at $102.77 (~$678K)
  • · COO Ye Gang sold 500 Class A ordinary shares at $103.74 (~$51.9K)
  • · COO Ye Gang sold 3,818 Class A ordinary shares at $105.02 (~$401K)
  • · COO Ye Gang sold 1,082 Class A ordinary shares at $105.52 (~$114K)
  • · COO Ye Gang sold 800 Class A ordinary shares at $105.66 (~$84.5K)
  • · COO Ye Gang sold 1,100 Class A ordinary shares at $106.72 (~$117K)
  • · COO Ye Gang sold 9,900 Class A ordinary shares at $107.83 (~$1.07M)
Home Federal Bancorp, Inc. of Louisiana 4 neutral materiality 4/10

10-07-2026

Director Lawrence Scott D exercised/converted 1,800 Common Stock at $11.86 (~$21.3K). Lawrence Scott D holds 77,092 shares after the transaction.

  • · Director Lawrence Scott D exercised/converted 1,800 Common Stock at $11.86 (~$21.3K)
  • · Director Lawrence Scott D exercised/converted 1,800 Stock Option (Right to Buy)
BARINGS CORPORATE INVESTORS 4 neutral materiality 3/10

10-07-2026

President Emery Christina acquired 43.3107 Barings Non-Qualified Thrift Plan at $17.35 (~$751).

  • · President Emery Christina acquired 43.3107 Barings Non-Qualified Thrift Plan at $17.35 (~$751)
Bluejay Diagnostics, Inc. 4 neutral materiality 4/10

10-07-2026

10% owner BANK OF AMERICA CORP /DE/ reported beneficial ownership in Bluejay Diagnostics, Inc.. No securities are beneficially owned.

CASEYS GENERAL STORES INC 4 negative materiality 6/10

10-07-2026

Chief Financial Officer Bramlage Stephen P JR sold 5,700 Common Stock at $838.16 (~$4.78M). Bramlage Stephen P JR holds 29,677 shares after the transaction.

  • · Chief Financial Officer Bramlage Stephen P JR sold 5,700 Common Stock at $838.16 (~$4.78M)
Koil Energy Solutions, Inc. 4 neutral materiality 4/10

10-07-2026

Director Carden Mark exercised/converted 50,000 Common Stock at $0.72 (~$36K). Carden Mark holds 110,980 shares after the transaction.

  • · Director Carden Mark exercised/converted 50,000 Common Stock at $0.72 (~$36K)
  • · Director Carden Mark exercised/converted 50,000 Stock Option at $0.72 (~$36K)
Athira Pharma, Inc. 4 neutral materiality 5/10

10-07-2026

Director PERCEPTIVE ADVISORS LLC was awarded 28,000 Stock Option (Right to Buy).

  • · Director PERCEPTIVE ADVISORS LLC was awarded 28,000 Stock Option (Right to Buy)
Mama's Creations, Inc. 4 negative materiality 3/10

10-07-2026

Chief Operating Officer Tappan Moore III sold 472 Common Stock at $18.65 (~$8.8K). Tappan Moore III holds 12,869 shares after the transaction.

  • · Chief Operating Officer Tappan Moore III sold 472 Common Stock at $18.65 (~$8.8K)
Angel Oak Financial Strategies Income Term Trust 4 positive materiality 5/10

10-07-2026

10% owner MetLife Investment Management, LLC bought 40,000,000 5.364% Series C Senior Unsecured Notes due July 8, 2030 at $40,000,000.00 (~$1600T).

  • · 10% owner MetLife Investment Management, LLC bought 40,000,000 5.364% Series C Senior Unsecured Notes due July 8, 2030 at $40,000,000.00 (~$1600T)
Joint Stock Co Kaspi.kz 4 negative materiality 4/10

10-07-2026

Director Kim Vyacheslav sold 6,491 American Depositary Shares, no par value at $87.35 (~$567K). 4 transactions reported in total. Trades executed under a Rule 10b5-1 plan.

  • · Director Kim Vyacheslav sold 6,491 American Depositary Shares, no par value at $87.35 (~$567K)
  • · Director Kim Vyacheslav sold 1,215 American Depositary Shares, no par value at $87.82 (~$107K)
  • · Director Kim Vyacheslav sold 2,934 American Depositary Shares, no par value at $87.50 (~$257K)
  • · Director Kim Vyacheslav sold 4,149 American Depositary Shares, no par value at $88.61 (~$368K)
PSQ Holdings, Inc. 4 neutral materiality 4/10

10-07-2026

Director Masters Blake was awarded 258,929 Class A Common Stock, par value $0.0001 per share. Masters Blake holds 442,827 shares after the transaction.

  • · Director Masters Blake was awarded 258,929 Class A Common Stock, par value $0.0001 per share
Yellowstone Midco Holdings II, LLC 4 neutral materiality 5/10

10-07-2026

10% owner AEROEQUITY GP, LLC was awarded 2,289,366 Common Stock, par value $0.0001 per share at $34.00 (~$77.8M). AEROEQUITY GP, LLC holds 32,915,588 shares after the transaction.

  • · 10% owner AEROEQUITY GP, LLC was awarded 2,289,366 Common Stock, par value $0.0001 per share at $34.00 (~$77.8M)
DOMINOS PIZZA INC 4 negative materiality 6/10

10-07-2026

EVP, Chief Tech & Data Ofcr GARCIA KELLY E sold 487 Common Stock, $0.01 par value at $297.01 (~$145K). GARCIA KELLY E holds 9,351.818 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · EVP, Chief Tech & Data Ofcr GARCIA KELLY E exercised/converted 487 Common Stock, $0.01 par value at $136.89 (~$66.7K)
  • · EVP, Chief Tech & Data Ofcr GARCIA KELLY E sold 487 Common Stock, $0.01 par value at $297.01 (~$145K)
  • · EVP, Chief Tech & Data Ofcr GARCIA KELLY E exercised/converted 487 Option to Purchase Common Stock
SEMTECH CORP 4 negative materiality 4/10

10-07-2026

EVP and COO Silberstein Asaf sold 3,354 Common Stock at $129.94 (~$436K). 6 transactions reported in total. Silberstein Asaf holds 96,862 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · EVP and COO Silberstein Asaf sold 437 Common Stock at $124.19 (~$54.3K)
  • · EVP and COO Silberstein Asaf sold 2,448 Common Stock at $125.18 (~$306K)
  • · EVP and COO Silberstein Asaf sold 273 Common Stock at $126.60 (~$34.6K)
  • · EVP and COO Silberstein Asaf sold 588 Common Stock at $127.61 (~$75K)
  • · EVP and COO Silberstein Asaf sold 1,400 Common Stock at $128.70 (~$180K)
  • · EVP and COO Silberstein Asaf sold 3,354 Common Stock at $129.94 (~$436K)
HERSHEY CO 4 neutral materiality 5/10

10-07-2026

SVP Chief Supply Chain Officer Arends Mitchell Andrew was awarded 3,843 Common Stock. Arends Mitchell Andrew holds 3,843 shares after the transaction.

  • · SVP Chief Supply Chain Officer Arends Mitchell Andrew was awarded 3,843 Common Stock
DOMINOS PIZZA INC 4 neutral materiality 3/10

10-07-2026

EVP, Chief HR Officer PITTENGER MAUREEN had withheld for taxes 229 Common Stock, $0.01 par value at $302.35 (~$69.2K). PITTENGER MAUREEN holds 3,289.265 shares after the transaction.

  • · EVP, Chief HR Officer PITTENGER MAUREEN had withheld for taxes 229 Common Stock, $0.01 par value at $302.35 (~$69.2K)
C. H. ROBINSON WORLDWIDE, INC. 4 neutral materiality 5/10

10-07-2026

Chief Financial Officer Lee Damon J. had withheld for taxes 4,698 Common Stock at $190.95 (~$897K). Lee Damon J. holds 36,736 shares after the transaction.

  • · Chief Financial Officer Lee Damon J. had withheld for taxes 4,698 Common Stock at $190.95 (~$897K)
ServiceTitan, Inc. 4 neutral materiality 3/10

10-07-2026

Director Deeter Byron B sold 0 Class A Common Stock.

  • · Director Deeter Byron B sold 0 Class A Common Stock
  • · Director Deeter Byron B sold 0 Class A Common Stock
HORMEL FOODS CORP /DE/ 4 negative materiality 6/10

10-07-2026

Director Bhojwani Gary C. sold 20,200 Common Stock at $24.51 (~$495K). Bhojwani Gary C. holds 32,002 shares after the transaction.

  • · Director Bhojwani Gary C. sold 20,200 Common Stock at $24.51 (~$495K)
INSMED Inc 4 negative materiality 7/10

10-07-2026

Chair and CEO Lewis William sold 5,005 Common Stock at $116.55 (~$583K). 7 transactions reported in total. Lewis William holds 259,058 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chair and CEO Lewis William exercised/converted 6,259 Common Stock at $30.46 (~$191K)
  • · Chair and CEO Lewis William exercised/converted 4,440 Common Stock at $17.16 (~$76.2K)
  • · Chair and CEO Lewis William sold 5,005 Common Stock at $116.55 (~$583K)
  • · Chair and CEO Lewis William sold 2,335 Common Stock at $117.62 (~$275K)
  • · Chair and CEO Lewis William sold 3,359 Common Stock at $118.52 (~$398K)
  • · Chair and CEO Lewis William exercised/converted 6,259 Stock Option (right to buy)
  • · Chair and CEO Lewis William exercised/converted 4,440 Stock Option (right to buy)
Maris Tech Ltd. 4 neutral materiality 4/10

10-07-2026

Malka Hananya was awarded 88,451 Ordinary shares. Malka Hananya holds 88,451 shares after the transaction.

  • · Malka Hananya was awarded 88,451 Ordinary shares
UNITED THERAPEUTICS Corp 4 negative materiality 6/10

10-07-2026

Director MALCOLM JAN sold 325 Common Stock at $550.59 (~$179K). MALCOLM JAN holds 450 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director MALCOLM JAN exercised/converted 650 Common Stock
  • · Director MALCOLM JAN sold 325 Common Stock at $550.59 (~$179K)
  • · Director MALCOLM JAN exercised/converted 650 Restricted Stock Unit
Maris Tech Ltd. 4 neutral materiality 4/10

10-07-2026

Bastiker Carmela was awarded 125,951 Ordinary shares. Bastiker Carmela holds 125,951 shares after the transaction.

  • · Bastiker Carmela was awarded 125,951 Ordinary shares
Maris Tech Ltd. 4 neutral materiality 5/10

10-07-2026

Chief Financial Officer Bussy Nir was awarded 125,951 Ordinary shares. Bussy Nir holds 125,951 shares after the transaction.

  • · Chief Financial Officer Bussy Nir was awarded 125,951 Ordinary shares
Planet Labs PBC 4 neutral materiality 5/10

10-07-2026

Director Raymond John w was awarded 6,479 Class A Common Stock. Raymond John w holds 50,087 shares after the transaction.

  • · Director Raymond John w was awarded 6,479 Class A Common Stock
LOWES COMPANIES INC 4 neutral materiality 3/10

10-07-2026

Director DREILING RICHARD W was awarded 258.216 Phantom Stock at $213.00 (~$55K).

  • · Director DREILING RICHARD W was awarded 258.216 Phantom Stock at $213.00 (~$55K)
Ally Financial Inc. 4 neutral materiality 3/10

10-07-2026

Director GIBBONS THOMAS P was awarded 1,034 Common Stock at $45.95 (~$47.5K). GIBBONS THOMAS P holds 26,062 shares after the transaction.

  • · Director GIBBONS THOMAS P was awarded 1,034 Common Stock at $45.95 (~$47.5K)
Planet Labs PBC 4 neutral materiality 4/10

10-07-2026

Director Reese Scott was awarded 6,479 Class A Common Stock. Reese Scott holds 17,446 shares after the transaction.

  • · Director Reese Scott was awarded 6,479 Class A Common Stock
  • · Director Reese Scott was awarded 2,160 Class A Common Stock
Newton Golf Company, Inc. 4 neutral materiality 5/10

10-07-2026

Director Hoge Brett Widney was awarded 3,246.66 Series A Convertible Preferred Stock at $95.24 (~$309K).

  • · Director Hoge Brett Widney was awarded 3,246.66 Series A Convertible Preferred Stock at $95.24 (~$309K)
  • · Director Hoge Brett Widney was awarded 2,164.44 Series A Convertible Preferred Stock at $95.24 (~$206K)
Ally Financial Inc. 4 neutral materiality 3/10

10-07-2026

Director Bright Gunther was awarded 300 Common Stock at $45.95 (~$13.8K). Bright Gunther holds 6,466 shares after the transaction.

  • · Director Bright Gunther was awarded 300 Common Stock at $45.95 (~$13.8K)
Planet Labs PBC 4 neutral materiality 3/10

10-07-2026

Director Gadde Vijaya was awarded 6,479 Class A Common Stock. Gadde Vijaya holds 256,648 shares after the transaction.

  • · Director Gadde Vijaya was awarded 6,479 Class A Common Stock
AGIOS PHARMACEUTICALS, INC. 4 neutral materiality 5/10

10-07-2026

Director Backstrom Jay T. was awarded 1,447 Common stock. Backstrom Jay T. holds 1,447 shares after the transaction.

  • · Director Backstrom Jay T. was awarded 1,447 Common stock
  • · Director Backstrom Jay T. exercised/converted 1,447 Restricted stock units
LOWES COMPANIES INC 4 neutral materiality 3/10

10-07-2026

Director DOUGLAS LAURIE Z was awarded 70.423 Phantom Stock at $213.00 (~$15K).

  • · Director DOUGLAS LAURIE Z was awarded 70.423 Phantom Stock at $213.00 (~$15K)
HEALTHEQUITY, INC. 4 neutral materiality 4/10

10-07-2026

EVP, CHIEF COMMERCIAL OFFICER Fiore Michael Henry had withheld for taxes 2,045 Common Stock at $95.08 (~$194K). Fiore Michael Henry holds 54,598 shares after the transaction.

  • · EVP, CHIEF COMMERCIAL OFFICER Fiore Michael Henry had withheld for taxes 2,045 Common Stock at $95.08 (~$194K)
BENTLEY SYSTEMS INC 4 neutral materiality 3/10

10-07-2026

Chief Legal Officer Shaman David R. had withheld for taxes 704 Class B Common Stock at $31.65 (~$22.3K). Shaman David R. holds 629,731 shares after the transaction.

  • · Chief Legal Officer Shaman David R. had withheld for taxes 704 Class B Common Stock at $31.65 (~$22.3K)
Planet Labs PBC 4 neutral materiality 3/10

10-07-2026

Director BASS CARL was awarded 6,479 Class A Common Stock. BASS CARL holds 406,545 shares after the transaction.

  • · Director BASS CARL was awarded 6,479 Class A Common Stock
  • · Director BASS CARL was awarded 2,880 Class A Common Stock
Planet Labs PBC 4 neutral materiality 4/10

10-07-2026

Director Brennan Ita M was awarded 6,479 Class A Common Stock. Brennan Ita M holds 261,873 shares after the transaction.

  • · Director Brennan Ita M was awarded 6,479 Class A Common Stock
  • · Director Brennan Ita M was awarded 2,736 Class A Common Stock
VALVOLINE INC 4 neutral materiality 4/10

10-07-2026

President & CEO Flees Lori Ann was awarded 25 Deferred Stock Units at $37.98 (~$950).

  • · President & CEO Flees Lori Ann was awarded 25 Deferred Stock Units at $37.98 (~$950)
Seres Therapeutics, Inc. 4 neutral materiality 5/10

10-07-2026

Director Graves Kurt was awarded 6,500 Stock Option (right to buy).

  • · Director Graves Kurt was awarded 6,500 Stock Option (right to buy)
Immunovant, Inc. 4 negative materiality 4/10

10-07-2026

Chief Operating Officer Gloria Melanie sold 1,930 Common Stock at $39.53 (~$76.3K). Gloria Melanie holds 222,357 shares after the transaction.

  • · Chief Operating Officer Gloria Melanie sold 1,930 Common Stock at $39.53 (~$76.3K)
  • · Chief Operating Officer Gloria Melanie sold 106 Common Stock at $39.99 (~$4.24K)
Seres Therapeutics, Inc. 4 neutral materiality 5/10

10-07-2026

See Remarks Kender Richard N was awarded 50,000 Stock Option (right to buy).

  • · See Remarks Kender Richard N was awarded 50,000 Stock Option (right to buy)
Tempus AI, Inc. 4 negative materiality 6/10

10-07-2026

CEO, Data Fukushima Ryan sold 13,984 Class A Common Stock at $56.80 (~$794K). 4 transactions reported in total. Fukushima Ryan holds 167,763 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CEO, Data Fukushima Ryan sold 13,984 Class A Common Stock at $56.80 (~$794K)
  • · CEO, Data Fukushima Ryan sold 13,686 Class A Common Stock at $57.37 (~$785K)
  • · CEO, Data Fukushima Ryan sold 3,477 Class A Common Stock at $58.55 (~$204K)
  • · CEO, Data Fukushima Ryan sold 2,137 Class A Common Stock at $59.47 (~$127K)
JFrog Ltd 4 negative materiality 5/10

10-07-2026

CHIEF EXECUTIVE OFFICER Shlomi Ben Haim sold 7,755 Ordinary Shares at $94.72 (~$735K). Shlomi Ben Haim holds 4,577,237 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CHIEF EXECUTIVE OFFICER Shlomi Ben Haim sold 5,845 Ordinary Shares at $93.65 (~$547K)
  • · CHIEF EXECUTIVE OFFICER Shlomi Ben Haim sold 7,755 Ordinary Shares at $94.72 (~$735K)
  • · CHIEF EXECUTIVE OFFICER Shlomi Ben Haim sold 1,400 Ordinary Shares at $95.42 (~$134K)
Seres Therapeutics, Inc. 4 neutral materiality 5/10

10-07-2026

Director Dere Willard H was awarded 6,500 Stock Option (right to buy).

  • · Director Dere Willard H was awarded 6,500 Stock Option (right to buy)
Seres Therapeutics, Inc. 4 neutral materiality 5/10

10-07-2026

Director Ausiello Dennis A was awarded 6,500 Stock Option (right to buy).

  • · Director Ausiello Dennis A was awarded 6,500 Stock Option (right to buy)
Seres Therapeutics, Inc. 4 neutral materiality 4/10

10-07-2026

See Remarks Henn Matthew R was awarded 25,000 Stock Option (right to buy).

  • · See Remarks Henn Matthew R was awarded 25,000 Stock Option (right to buy)
Seres Therapeutics, Inc. 4 neutral materiality 4/10

10-07-2026

See Remarks Thorell Marella was awarded 7,500 Stock Option (right to buy).

  • · See Remarks Thorell Marella was awarded 7,500 Stock Option (right to buy)

Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Insider Trading Pulse

July 08, 2026

Insider Trading Pulse — July 08, 2026

July 07, 2026

Insider Trading Pulse — July 07, 2026

July 06, 2026

Insider Trading Pulse — July 06, 2026

July 02, 2026

Insider Trading Pulse — July 02, 2026

🇺🇸 More from United States

View all →

July 13, 2026

US Pre-Market SEC Filings Roundup — July 13, 2026

US Pre-Market SEC Filings Roundup

July 13, 2026

US Merger & Acquisition SEC Filings — July 13, 2026

US Merger & Acquisition SEC Filings

July 13, 2026

USA Insider Trading Pulse — July 13, 2026

USA Insider Trading Pulse

July 13, 2026

US Corporate Board Director Changes SEC Filings — July 13, 2026

US Corporate Board Director Changes SEC Filings
← All United States digests